Department of Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine
HOME
HOMEPublications2008
About Our Department
Research Contents
Osaka University, Graduate School of Medicine / Faculty of Medicine
Osaka University
Publications
1994 1995 1996 1997 1998 1999 2000 2001 2002
2003 2004 2005 2006 2007 2009 2010 2011
2008
  1. Kimura Y, Kitagawa K, Oku N, Kajimoto K, Kato H, Tanaka M, Sakaguchi M, Hougaku H, Sakoda S, Hatazawa J. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions. Hypertens Res. 31:2147-2154, 2008.
  2. Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, Takiguchi S, Higuchi I, Hatazawa J, Monden M. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 144:793-802, 2008.
  3. Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Ann Nucl Med. 22:795-802, 2008.
  4. Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yshikawa H, Aozasa K, Hatazawa J. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Ann Nucl Med. 22:699-705, 2008.
  5. Inohara H, Enomoto K, Tomiyama Y, Yoshii T, Osaki Y, Higuchi I, Inoue T, Hatazawa J. The role of CT and (18)F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol. 7:1-7, 2008.
  6. Kato H, Yoshikawa T, Oku N, Imaizumi M, Takasawa M, Kimura Y, Kajimoto K, Tanaka M, Kitagawa K, Hori M, Hatazawa J. Statistical parametric analysis of cerebral blood flow in vascular dementia with small-vessel disease using Tc-HMPAO SPECT. Cerebrovasc Dis. 26:556-562, 2008.
  7. Shimamoto H, Tatsumi M, Kakimoto N, Hamada S, Shimosegawa E, Murakami S, Furukawa S, Hatazawa J. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT. Ann Nucl Med. 22:587-593, 2008.
  8. Hasegawa S, Yamamoto K, Sakata Y, Takeda Y, Kajimoto K, Kanai Y, Hori M, Hatazawa J. Effects of cardiac energy efficiency in diastolic heart failure: assessment with positron emission tomography with 11C-acetate. Hypertens Res. 31:1157-1162, 2008.
  9. Tanaka M, Shimosegawa E, Kajimoto K, Kimura Y, Kato H, Oku N, Hori M, Kitagawa K, Hatazawa J. Chronic middle cerebral artery occlusion: a hemodynamic and metabolic study with positron-emission tomography. AJNR Am J Neuroradiol. 29:1841-1846, 2008.
  10. Hayashi T, Suzuki A, Hatazawa J, Hadeishi H, Shirane R, Tominaga T, Yasui N. Post-operative changes of cerebral circulation and metabolism in the acute stage of low-grade aneurysmal subarachnoid hemorrhage. Neurol Res. 30:678-683, 2008.
  11. Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, Tatsumi M, Fukunaga H, Takiguchi S, Fujiwara Y, Hatazawa J, Monden M. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 136:205-212, 212.e1-3, 2008.
  12. Hasegawa Y, Kanai Y, Hasegawa S, Okamoto T, Matsui T, Shimosegawa E, Kurachi Y, Hatazawa J. Evaluation of brain and whole-body pharmacokinetics of 11C-labeled diphenylhydantoin in rats by means of planar positron imaging system. Ann Nucl Med. 22:301-307, 2008.
  13. Enomoto K, Hamada K, Inohara H, Higuchi I, Tomita Y, Kubo T, Hatazawa J. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings. Ann Nucl Med. 22:261-267, 2008.
  14. Enomoto K, Inohara H, Higuchi I, Hamada K, Tomiyama Y, Kubo T, Hatazawa J. Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy. Mol Imaging Biol. 10:224-229, 2008.
  15. Takao T, Tsujimura A, Miyagawa Y, Kiuchi H, Ueda T, Hirai T, Komori K, Takada S, Nonomura N, Osaki Y, Enomoto K, Hatazawa J, Okuyama A. Brain responses during the first desire to void: a positron emission tomography study. Int J Urol. 15:724-728, 2008.
  16. Kato H, Shimosegawa E, Oku N, Kimura Y, Kajimoto K, Tanaka M, Hori M, Kitagawa K, Hatazawa J. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions. Cerebrovasc Dis. 26:9-15, 2008.
  17. Enomoto K, Inohara H, Hamada K, Tamura M, Tomita Y, Kubo T, Hatazawa J. FDG PET imaging of myxofibrosarcoma on the sphenoid sinus. Clin Nucl Med. 33:421-422, 2008.
  18. Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H, Yoshimine T. Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg. 108:963-971, 2008.
  19. Kato H, Shimosegawa E, Oku N, Kitagawa K, Kishima H, Saitoh Y, Kato A, Yoshimine T, Hatazawa J. MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images. J Nucl Med. 49:383-389, 2008.
  20. Amitani M, Ohashi A, Hatazawa J, Gee A, Inoue O. Effect of PK11195 on attenuating the enhancement of glucose utilization induced by quinolinic acid infusion in the rat brain. Synapse. 62:253-258, 2008.
  21. Enomoto K, Nishimura H, Hamada K, Doi K, Kubo T, Hatazawa J. Nuclear imaging of osteoma. Clin Nucl Med. 33:135-136, 2008.
  22. Fujimura Y, Hwang PM, Trout Iii H, Kozloff L, Imaizumi M, Innis RB, Fujita M. Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: An autoradiographic study with [(3)H]PK 11195. Atherosclerosis. 2008 Mar 14. [Epub ahead of print]
  23. Fujita M, Imaizumi M, Zoghbi SS, Fujimura Y, Farris AG, Suhara T, Hong J, Pike VW, Innis RB. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage. 40:43-52, 2008.
  24. Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem. 51:17-30, 2008.
  25. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage. 39:1289-1298, 2008.
  26. Takasawa M, Moustafa RR, Baron JC. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke. 39:1629-1637, 2008.
  27. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke. 39:870-877, 2008.
1994 1995 1996 1997 1998 1999 2000 2001 2002
2003 2004 2005 2006 2007 2009 2010 2011
Copyright (C) Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, All Rights Reserved.